BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 29969630)

  • 21. SNHG1 promotes MPP
    Zhao J; Geng L; Chen Y; Wu C
    Biol Res; 2020 Jan; 53(1):1. PubMed ID: 31907031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
    Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L
    Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-212-3p improves rat functional recovery and inhibits neurocyte apoptosis in spinal cord injury models via PTEN downregulation-mediated activation of AKT/mTOR pathway.
    Guan C; Luan L; Li J; Yang L
    Brain Res; 2021 Oct; 1768():147576. PubMed ID: 34216580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN.
    Li H; Huhe M; Lou J
    Biomed Res Int; 2021; 2021():7590976. PubMed ID: 34307670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway.
    Zheng Y; Yang X; Wang C; Zhang S; Wang Z; Li M; Wang Y; Wang X; Yang X
    Sci Rep; 2020 Feb; 10(1):3576. PubMed ID: 32107418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
    Li Y; Gu J; Lu H
    Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
    Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
    Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2.
    Song BF; Xu LZ; Jiang K; Cheng F
    Funct Integr Genomics; 2023 Mar; 23(2):80. PubMed ID: 36884182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor suppressor miR-361-3p inhibits prostate cancer progression through Gli1 and AKT/mTOR signaling pathway.
    Wang S; Huang X; Zhang G; Chen Z; Guan H; Zhou W
    Cell Signal; 2024 Feb; 114():110998. PubMed ID: 38048859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
    Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
    Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significantly altered expression of miR-511-3p and its target AKT3 has negative prognostic value in human prostate cancer.
    Zhang F; Wu Z
    Biochimie; 2017 Sep; 140():66-72. PubMed ID: 28624527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-17-5p knockdown inhibits proliferation, autophagy and promotes apoptosis in thyroid cancer via targeting PTEN.
    Shi YP; Liu GL; Li S; Liu XL
    Neoplasma; 2020 Mar; 67(2):249-258. PubMed ID: 31973533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT/mTOR pathway.
    Li D; Li P; Guo Z; Wang H; Pan W
    Int J Mol Med; 2017 Mar; 39(3):757-763. PubMed ID: 28112362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met.
    Gao S; Zhao Z; Wu R; Wu L; Tian X; Zhang Z
    Biomed Pharmacother; 2019 Jan; 109():1406-1410. PubMed ID: 30551391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
    Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
    Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-203a-3p targets PTEN to promote hepatocyte proliferation by regulating PI3K/Akt pathway in BRL-3A cells.
    Zhang Y; Zheng Y; Zhu G
    Biosci Biotechnol Biochem; 2020 Apr; 84(4):725-733. PubMed ID: 31814541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-92a-3p enhances functional recovery and suppresses apoptosis after spinal cord injury via targeting phosphatase and tensin homolog.
    He S; Wang Z; Li Y; Dong J; Xiang D; Ren L; Guo L; Shu J
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32297644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.